Boricka - you would be amazed to see the list of sound and prudent business moves the Interim CEO and a re-motivated BIEL team have planned for when the current CBO, CEO follows through his stated to retire he shared with several people in March. Several of your points are on the list. He must simply shift over to Chairman of the Board with a non-interference contract and let a new and competent team make his family wealthy, as he is the shareholder controlling about 25 billion shares tied up in convertible notes tucked away in IBEX.
It is outrageous that a pink sheet stock of a company with a magical, drug-free, side-effect free, efficacious, inexpensive acute and chronic pain device only rises .0002 after the FDA clearance for RecoveryRx we all just witnessed. So clearly the path forward is obvious. The current CBO, CEO actually believes he is the ONLY one on earth who can manage the company forward to success. Proof positive of a huge case of Founder's Syndrome, failing health and advancing aging issues, to the point that he cannot see the obvious with clarity and therefor cannot get out of his own way.
At the risk of being repetitious, please allow me to present a few earlier opinions that may provide clarity, again.
First
There must be no sides or conflicts among stockholders wishing and deserving competent management. There must be one goal, one focus, success. It's only about deals, sales, profits and stockholder equity.
ActiPatch has helped and continues to help many here and potentially hundreds of millions globally and it's a consumable! How incredibly stupid would it be to blow an FDA cleared consumable pain device product line? Because a failing CBO, CEO stubbornly didn't want to retire and become wealthy? World Class stupid, that's what!
A magical, breakthrough pain management device like ActiPatch cannot fail to deliver, but incompetent management and Founder's Syndrome can and have. Imploded deals with Bayer/Dr. Scholl's, KT Tape and CVS caused only by the CBO, CEO are facts. Again, only facts matter, not speculation, not hype and certainly not blame. We need to fix the problem, not the blame. The current CBO, CEO was, repeat, was a good start-up guy and deserves all the credit in the world. But, that was then, this is now and in his best years he never managed a regulated, pharma related public company to success.
Imagine what BIEL would be trading at this moment had Whelan retired to Chairman only with a non-interference commitment and the competent management team and cash injection he and his daughter also said "No" to in April? Imagine a turned on BIEL team pounding the retail pavement making deals?
As said, if the CBO, CEO is not an inept, over the hill, bungler, the stock price should have risen just with speculation of real deals and sales, that's how markets react and discount great news early. If he is an inept, over the hill, bungler, then the price will stay in the toilet and he needs to retire, as he declared to several people he wished to in March.. Simple.
A stock running because of a regulatory clearance, which BIEL products have deserved for years, is not indicative of competent management. Imagine what the company and the share price could easily do, if both components were present.... pick a number, it would only be going up. A CBO, CEO retirement to Chair will be bigger than FDA clearance.
---------------------------------
And . . . .
Please allow me to share my opinion with greater clarity......
A stock running because of a regulatory clearance, which BIEL products have deserved for years, is not indicative of competent management.
Imagine what the company and the share price could easily do, if both components and all conditions stockholders deserve and which were not only present, but within grasp...were present:
More FDA clearances - .004;
Bayer/Dr. Scholl's - .009, directly imploded by current CBO, CEO;
KT Tape - .015, directly imploded by current CBO, CEO;
CVS - .04, directly imploded by current CBO, CEO; and
Competent management - .075
Now add on Walmart, Walgreen's. Va . . . Just imagine. Sound familiar? I wrote this 2+ years and 8 billion shares ago.
As said, if the CBO, CEO is not an inept, over the hill, bungler, the stock price should have risen just with speculation of real deals and sales, that's how markets react and discount great news early. If he is an inept, over the hill, bungler, then the price will stay in the toilet and he needs to retire. Simple. A stock running because of a regulatory clearance, which BIEL products have deserved for years, is not indicative of competent management. Imagine what the company could easily do, if both components were present....
Managing a company successfully for its stockholders and employees is not difficult, if management has the aptitude. Without it or a good dose of me, me, me, Founder's Syndrome with aging and failing faculty issues, can make success, always, just out of reach or maybe next month or just around the next corner. A rise of .0002 on the announcement of an FDA clearance on RecoveryRX? Outrageous. is there still anyone not believing that it may just be time?
News 
Market Data 
Discover 
